Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
BioProcess Internation...BioProcess International US West
Not Confirmed
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
09-11 March, 2026
Not Confirmed
Not Confirmed
09-11 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BioProcess Internation...BioProcess International US West
Industry Trade Show
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
09-11 March, 2026
Industry Trade Show
Not Confirmed
09-11 March, 2026
Digital content

10 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ai-powered-rd-acceleration-insilico-medicine-and-cms-announce-multiple-collaborations-in-central-nervous-system-and-autoimmune-diseases-302683513.html

06 Feb 2026
// PR NEWSWIRE BIO
https://www.prnewswire.com/news-releases/insilico-medicine-appoints-halle-zhang-phd-med-as-vice-president-clinical-development--oncology-302681141.html

05 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/insilico-medicine-nominates-ism5059-the-peripheral-restricted-nlrp3-inhibitor-as-preclinical-candidate-for-the-treatment-of-multiple-inflammatory-and-metabolism-indications-302679925.html

03 Feb 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/insilico-medicine-receives-usd-5million-milestone-payment-from-menarini-group-following-first-in-human-fih-achievement-for-men2501-302676790.html

29 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/up-to-31-3-body-weight-loss-insilico-medicine-nominates-ai-powered-gipr-antagonist-ism0676-as-preclinical-candidate-showing-synergistic-efficacy-in-combination-therapy-302673640.html

27 Jan 2026
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/qilu-programs-path-cardiometabolic-disease-120m-ai-enabled-insilico-alliance
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE